TOKYO/SEOUL -- Imbalance in COVID-19 vaccine supply is deepening around the world. The U.S., EU and other nations that produce and export vaccines have surpluses totaling more than 150 million doses, while shortages have caused delays in vaccination in many countries in Asia.
A mechanism under which countries having surplus vaccines supply them to those in need is indispensable to facilitate vaccination on a global scale.